{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T21:27:44Z","timestamp":1791062864838,"version":"4.1.0"},"reference-count":64,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2013,2,20]],"date-time":"2013-02-20T00:00:00Z","timestamp":1361318400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,7,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>\u2003<\/jats:title>\n                    <jats:p>Osteonecrosis of the jaw (ONJ) is a well-recognized complication of antiresorptive medications, such as bisphosphonates (BPs). Although ONJ is most common after tooth extractions in patients receiving high-dose BPs, many patients do not experience oral trauma. Animal models using tooth extractions and high BP doses recapitulate several clinical, radiographic, and histologic findings of ONJ. We and others have reported on rat models of ONJ using experimental dental disease in the absence of tooth extraction. These models emphasize the importance of dental infection\/inflammation for ONJ development. Here, we extend our original report in the rat, and present a mouse model of ONJ in the presence of dental disease. Mice were injected with high dose zoledronic acid and pulpal exposure of mandibular molars was performed to induce periapical disease. After 8 weeks, quantitative and qualitative radiographic and histologic analyses of mouse mandibles were done. Periapical lesions were larger in vehicle-treated versus BP-treated mice. Importantly, radiographic features resembling clinical ONJ, including thickening of the lamina dura, periosteal bone deposition, and increased trabecular density, were seen in the drilled site of BP-treated animals. Histologically, osteonecrosis, periosteal thickening, periosteal bone apposition, epithelial migration, and bone exposure were present in the BP-treated animals in the presence of periapical disease. No difference in tartrate-resistant acid phosphatase (TRAP)+ cell numbers was observed, but round, detached, and removed from the bone surface cells were present in BP-treated animals. Although 88% of the BP-treated animals showed areas of osteonecrosis in the dental disease site, only 33% developed bone exposure, suggesting that osteonecrosis precedes bone exposure. Our data further emphasize the importance of dental disease in ONJ development, provide qualitative and quantitative measures of ONJ, and present a novel mouse ONJ model in the absence of tooth extraction that should be useful in further exploring ONJ pathophysiological mechanisms.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/jbmr.1894","type":"journal-article","created":{"date-parts":[[2013,2,20]],"date-time":"2013-02-20T16:25:07Z","timestamp":1361377507000},"page":"1631-1640","source":"Crossref","is-referenced-by-count":114,"title":["Periapical Disease and Bisphosphonates Induce Osteonecrosis of the Jaws in Mice"],"prefix":"10.1093","volume":"28","author":[{"given":"Ben","family":"Kang","sequence":"first","affiliation":[{"name":"Division of Diagnostic and Surgical SciencesUCLA School of DentistryLos Angeles, CAUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Cheong","sequence":"additional","affiliation":[{"name":"Division of Diagnostic and Surgical SciencesUCLA School of DentistryLos Angeles, CAUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thawinee","family":"Chaichanasakul","sequence":"additional","affiliation":[{"name":"Division of Diagnostic and Surgical SciencesUCLA School of DentistryLos Angeles, CAUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Bezouglaia","sequence":"additional","affiliation":[{"name":"Division of Diagnostic and Surgical SciencesUCLA School of DentistryLos Angeles, CAUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Atti","sequence":"additional","affiliation":[{"name":"Division of Diagnostic and Surgical SciencesUCLA School of DentistryLos Angeles, CAUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah M","family":"Dry","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory MedicineDavid Geffen School of Medicine at UCLALos Angeles, CAUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia Q","family":"Pirih","sequence":"additional","affiliation":[{"name":"Division of Associated SpecialtiesUCLA School of DentistryLos Angeles, CAUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara L","family":"Aghaloo","sequence":"additional","affiliation":[{"name":"Division of Diagnostic and Surgical SciencesUCLA School of DentistryLos Angeles, CAUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sotirios","family":"Tetradis","sequence":"additional","affiliation":[{"name":"Molecular Biology Institute, UCLALos Angeles, CAUSA"},{"name":"Division of Diagnostic and Surgical SciencesUCLA School of DentistryLos Angeles, CAUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,2,20]]},"reference":[{"key":"2024020318380409200_jbmr1894-bib-0001","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000151371","article-title":"Bisphosphonates and osteonecrosis of the jaw: moving from the bedside to the bench","volume":"189","author":"Allen","year":"2009","journal-title":"Cells Tissues Organs."},{"key":"2024020318380409200_jbmr1894-bib-0002","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bone.2011.04.022","article-title":"Bisphosphonates: the first 40 years","volume":"49","author":"Russell","year":"2011","journal-title":"Bone."},{"key":"2024020318380409200_jbmr1894-bib-0003","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00198-007-0540-8","article-title":"Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy","volume":"19","author":"Russell","year":"2008","journal-title":"Osteoporos Int."},{"key":"2024020318380409200_jbmr1894-bib-0004","doi-asserted-by":"crossref","first-page":"6222s","DOI":"10.1158\/1078-0432.CCR-06-0843","article-title":"Molecular mechanisms of action of bisphosphonates: current status","volume":"12","author":"Roelofs","year":"2006","journal-title":"Clin Cancer Res."},{"key":"2024020318380409200_jbmr1894-bib-0005","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S8756-3282(99)00116-7","article-title":"Bisphosphonates: from the laboratory to the clinic and back again","volume":"25","author":"Russell","year":"1999","journal-title":"Bone."},{"key":"2024020318380409200_jbmr1894-bib-0006","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1172\/JCI115539","article-title":"Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure","volume":"88","author":"Sato","year":"1991","journal-title":"J Clin Invest."},{"key":"2024020318380409200_jbmr1894-bib-0007","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1124\/mol.105.020776","article-title":"Cytosolic entry of bisphosphonate drugs requires acidification of vesicles after fluid-phase endocytosis","volume":"69","author":"Thompson","year":"2006","journal-title":"Mol Pharmacol."},{"key":"2024020318380409200_jbmr1894-bib-0008","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ctrv.2008.02.004","article-title":"Exploring the anti-tumour activity of bisphosphonates in early breast cancer","volume":"34","author":"Winter","year":"2008","journal-title":"Cancer Treat Rev."},{"key":"2024020318380409200_jbmr1894-bib-0009","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1359\/jbmr.1998.13.4.581","article-title":"Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras","volume":"13","author":"Luckman","year":"1998","journal-title":"J Bone Miner Res."},{"key":"2024020318380409200_jbmr1894-bib-0010","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1177\/154405910708601102","article-title":"Mechanism of action, pharmacokinetic and pharmacodynamic profile, and clinical applications of nitrogen-containing bisphosphonates","volume":"86","author":"Kimmel","year":"2007","journal-title":"J Dent Res."},{"key":"2024020318380409200_jbmr1894-bib-0011","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/cncr.21130","article-title":"Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy","volume":"104","author":"Migliorati","year":"2005","journal-title":"Cancer."},{"key":"2024020318380409200_jbmr1894-bib-0012","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000201931","article-title":"Combination of bisphosphonates and antiangiogenic factors induces osteonecrosis of the jaw more frequently than bisphosphonates alone","volume":"76","author":"Christodoulou","year":"2009","journal-title":"Oncology."},{"key":"2024020318380409200_jbmr1894-bib-0013","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.joms.2004.02.004","article-title":"Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases","volume":"62","author":"Ruggiero","year":"2004","journal-title":"J Oral Maxillofac Surg."},{"key":"2024020318380409200_jbmr1894-bib-0014","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J Oral Maxillofac Surg."},{"key":"2024020318380409200_jbmr1894-bib-0015","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.joms.2005.07.010","article-title":"Bisphosphonate-induced exposed bone (osteonecrosis\/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment","volume":"63","author":"Marx","year":"2005","journal-title":"J Oral Maxillofac Surg."},{"key":"2024020318380409200_jbmr1894-bib-0016","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1749-6632.2010.05835.x","article-title":"Potential pathophysiological mechanisms in osteonecrosis of the jaw","volume":"1218","author":"Landesberg","year":"2011","journal-title":"Ann N Y Acad Sci."},{"key":"2024020318380409200_jbmr1894-bib-0017","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S1532-3382(12)70046-5","article-title":"Antiresorptives and osteonecrosis of the jaw","volume":"12","author":"Yamashita","year":"2012","journal-title":"J Evid Based Dent Pract."},{"key":"2024020318380409200_jbmr1894-bib-0018","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1749-6632.2012.06674.x","article-title":"The development of denosumab for the treatment of diseases of bone loss and cancer-induced bone destruction","volume":"1263","author":"Goessl","year":"2012","journal-title":"Ann N Y Acad Sci."},{"key":"2024020318380409200_jbmr1894-bib-0019","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s12020-012-9696-x","article-title":"Skeletal and extraskeletal actions of denosumab","volume":"42","author":"Sinningen","year":"2012","journal-title":"Endocrine."},{"key":"2024020318380409200_jbmr1894-bib-0020","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1016\/j.ejca.2012.08.002","article-title":"Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: a combined analysis of 3 pivotal, randomised, phase 3 trials","volume":"48","author":"Lipton","year":"2012","journal-title":"Eur J Cancer."},{"key":"2024020318380409200_jbmr1894-bib-0021","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ctrv.2012.07.002","article-title":"Denosumab in patients with cancer and skeletal metastases: a systematic review and meta-analysis","volume":"39","author":"Peddi","year":"2013","journal-title":"Cancer Treat Rev."},{"key":"2024020318380409200_jbmr1894-bib-0022","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1097\/JTO.0b013e31826aec2b","article-title":"Overall survival improvement in patients with lung cancer and bone metastases treated with denosumab versus zoledronic acid: subgroup analysis from a randomized phase 3 study","volume":"7","author":"Scagliotti","year":"2012","journal-title":"J Thorac Oncol."},{"key":"2024020318380409200_jbmr1894-bib-0023","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1600-0714.2011.01125.x","article-title":"Bisphosphonate-induced osteonecrosis of the jaw in a rat model arises first after the bone has become exposed. No primary necrosis in unexposed bone","volume":"41","author":"Abtahi","year":"2012","journal-title":"J Oral Pathol Med."},{"key":"2024020318380409200_jbmr1894-bib-0024","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1002\/jbmr.379","article-title":"Periodontal disease and bisphosphonates induce osteonecrosis of the jaws in the rat","volume":"26","author":"Aghaloo","year":"2011","journal-title":"J Bone Miner Res."},{"key":"2024020318380409200_jbmr1894-bib-0025","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1002\/jbmr.1669","article-title":"Oncologic doses of zoledronic acid induce osteonecrosis of the jaw-like lesions in rice rats (Oryzomys palustris) with periodontitis","volume":"27","author":"Aguirre","year":"2012","journal-title":"J Bone Miner Res."},{"key":"2024020318380409200_jbmr1894-bib-0026","doi-asserted-by":"crossref","first-page":"e879","DOI":"10.4317\/medoral.17150","article-title":"Extraction socket healing in rats treated with bisphosphonate: animal model for bisphosphonate related osteonecrosis of jaws in multiple myeloma patients","volume":"16","author":"Ali-Erdem","year":"2011","journal-title":"Med Oral Patol Oral Cir Bucal."},{"key":"2024020318380409200_jbmr1894-bib-0027","doi-asserted-by":"crossref","first-page":"280","DOI":"10.2353\/ajpath.2010.090592","article-title":"Bisphosphonates cause osteonecrosis of the jaw-like disease in mice","volume":"177","author":"Bi","year":"2010","journal-title":"Am J Pathol."},{"key":"2024020318380409200_jbmr1894-bib-0028","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/j.1600-0714.2010.00927.x","article-title":"An experimental study of bisphosphonate-induced jaws osteonecrosis in Sprague-Dawley rats","volume":"39","author":"Lopez-Jornet","year":"2010","journal-title":"J Oral Pathol Med."},{"key":"2024020318380409200_jbmr1894-bib-0029","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/jbmr.37","article-title":"Cell-based immunotherapy with mesenchymal stem cells cures bisphosphonate-related osteonecrosis of the jaw-like disease in mice","volume":"25","author":"Kikuiri","year":"2010","journal-title":"J Bone Miner Res."},{"key":"2024020318380409200_jbmr1894-bib-0030","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.oraloncology.2008.04.013","article-title":"Bony changes in the jaws of rats treated with zoledronic acid and dexamethasone before dental extractions mimic bisphosphonate-related osteonecrosis in cancer patients","volume":"45","author":"Sonis","year":"2009","journal-title":"Oral Oncol."},{"key":"2024020318380409200_jbmr1894-bib-0031","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.bone.2012.04.020","article-title":"Bisphosphonate related osteonecrosis of the jaw: a minipig large animal model","volume":"51","author":"Pautke","year":"2012","journal-title":"Bone."},{"key":"2024020318380409200_jbmr1894-bib-0032","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1200\/JCO.2007.12.1269","article-title":"American Society of Clinical Oncology 2007 clinical practice guideline update on the role of bisphosphonates in multiple myeloma","volume":"25","author":"Kyle","year":"2007","journal-title":"J Clin Oncol."},{"key":"2024020318380409200_jbmr1894-bib-0033","doi-asserted-by":"crossref","first-page":"5356","DOI":"10.1200\/JCO.2009.21.9584","article-title":"Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw","volume":"27","author":"Vahtsevanos","year":"2009","journal-title":"J Clin Oncol."},{"key":"2024020318380409200_jbmr1894-bib-0034","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ygyno.2008.11.029","article-title":"Bisphosphonate-induced osteonecrosis of the jaw (ONJ): Incidence and risk factors in patients with breast cancer and gynecological malignancies","volume":"112","author":"Fehm","year":"2009","journal-title":"Gynecol Oncol."},{"key":"2024020318380409200_jbmr1894-bib-0035","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1177\/00220345910700100901","article-title":"Kinetics of bone-resorbing activity in developing periapical lesions","volume":"70","author":"Wang","year":"1991","journal-title":"J Dent Res."},{"key":"2024020318380409200_jbmr1894-bib-0036","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.4049\/jimmunol.165.7.3626","article-title":"IL-10, but not IL-4, suppresses infection-stimulated bone resorption in vivo","volume":"165","author":"Sasaki","year":"2000","journal-title":"J Immunol."},{"key":"2024020318380409200_jbmr1894-bib-0037","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.nut.2005.04.002","article-title":"Comparing rat's to human's age: how old is my rat in people years?","volume":"21","author":"Quinn","year":"2005","journal-title":"Nutrition."},{"key":"2024020318380409200_jbmr1894-bib-0038","first-page":"2394","article-title":"Approval summary for zoledronic acid for treatment of multiple myeloma and cancer bone metastases","volume":"9","author":"Ibrahim","year":"2003","journal-title":"Clin Cancer Res."},{"key":"2024020318380409200_jbmr1894-bib-0039","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1056\/NEJM200507073530120","article-title":"Osteonecrosis of the jaw and bisphosphonates","volume":"353","author":"Maerevoet","year":"2005","journal-title":"N Engl J Med."},{"key":"2024020318380409200_jbmr1894-bib-0040","doi-asserted-by":"crossref","first-page":"4925","DOI":"10.1200\/JCO.2005.06.091","article-title":"Predictive value of bone resorption and formation markers in cancer patients with bone metastases receiving the bisphosphonate zoledronic acid","volume":"23","author":"Coleman","year":"2005","journal-title":"J Clin Oncol."},{"key":"2024020318380409200_jbmr1894-bib-0041","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1056\/NEJMcp042806","article-title":"Clinical practice. Hypercalcemia associated with cancer","volume":"352","author":"Stewart","year":"2005","journal-title":"N Engl J Med."},{"key":"2024020318380409200_jbmr1894-bib-0042","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.14219\/jada.archive.2000.0118","article-title":"The Surgeon General's report on America's oral health: opportunities for the dental profession","volume":"131","author":"Evans","year":"2000","journal-title":"J Am Dent Assoc."},{"key":"2024020318380409200_jbmr1894-bib-0043","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1038\/bcj.2012.9","article-title":"Evolution of bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma and Waldenstrom's macroglobulinemia: a retrospective multicentric study","volume":"2","author":"Andriani","year":"2012","journal-title":"Blood Cancer J."},{"key":"2024020318380409200_jbmr1894-bib-0044","first-page":"2","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws\u20142009 update","volume":"67","author":"Ruggiero","year":"2009","journal-title":"J Oral Maxillofac Surg."},{"key":"2024020318380409200_jbmr1894-bib-0045","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1056\/NEJMp068157","article-title":"Osteonecrosis of the jaw\u2014do bisphosphonates pose a risk?","volume":"355","author":"Bilezikian","year":"2006","journal-title":"N Engl J Med."},{"key":"2024020318380409200_jbmr1894-bib-0046","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/j.1600-051X.2005.00842.x","article-title":"Osteonecrosis of the jaws in periodontal patients with a history of bisphosphonates treatment","volume":"32","author":"Ficarra","year":"2005","journal-title":"J Clin Periodontol."},{"key":"2024020318380409200_jbmr1894-bib-0047","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.joms.2009.03.050","article-title":"Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure","volume":"68","author":"Lo","year":"2010","journal-title":"J Oral Maxillofac Surg."},{"key":"2024020318380409200_jbmr1894-bib-0048","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.joms.2006.10.061","article-title":"Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia","volume":"65","author":"Mavrokokki","year":"2007","journal-title":"J Oral Maxillofac Surg."},{"key":"2024020318380409200_jbmr1894-bib-0049","first-page":"968","article-title":"Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: evidence of increased risk after treatment with zoledronic acid","volume":"91","author":"Dimopoulos","year":"2006","journal-title":"Haematologica."},{"key":"2024020318380409200_jbmr1894-bib-0050","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/annonc\/mdn526","article-title":"Decreased occurrence of osteonecrosis of the jaw after implementation of dental preventive measures in solid tumour patients with bone metastases treated with bisphosphonates. The experience of the National Cancer Institute of Milan","volume":"20","author":"Ripamonti","year":"2009","journal-title":"Ann Oncol."},{"key":"2024020318380409200_jbmr1894-bib-0051","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1600-0765.1981.tb00995.x","article-title":"The progress of the periodontal syndrome in the rice cat. II. The effects of a diphosphonate on the periodontium","volume":"16","author":"Gotcher","year":"1981","journal-title":"J Periodontal Res."},{"issue":"2","key":"2024020318380409200_jbmr1894-bib-0052","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1177\/0022034512468757","article-title":"Inhibiting periapical lesions through AAV-RNAi silencing of cathepsin K","volume":"92","author":"Gao","year":"2013","journal-title":"J Dent Res."},{"key":"2024020318380409200_jbmr1894-bib-0053","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1399-302X.1997.tb00619.x","article-title":"Bone-resorptive cytokine gene expression in periapical lesions in the rat","volume":"12","author":"Wang","year":"1997","journal-title":"Oral Microbiol Immunol."},{"key":"2024020318380409200_jbmr1894-bib-0054","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.joms.2008.12.002","article-title":"Imaging findings in bisphosphonate-related osteonecrosis of jaws","volume":"67","author":"Arce","year":"2009","journal-title":"J Oral Maxillofac Surg."},{"key":"2024020318380409200_jbmr1894-bib-0055","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.tripleo.2007.08.040","article-title":"Bisphosphonate-associated jawbone osteonecrosis: a correlation between imaging techniques and histopathology","volume":"105","author":"Bedogni","year":"2008","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod."},{"key":"2024020318380409200_jbmr1894-bib-0056","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.tripleo.2007.01.040","article-title":"Computerized tomographic findings in bisphosphonate-associated osteonecrosis of the jaw in patients with cancer","volume":"104","author":"Bianchi","year":"2007","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod."},{"key":"2024020318380409200_jbmr1894-bib-0057","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00784-009-0311-3","article-title":"Bisphosphonate-related osteonecrosis of the jaw: clinical correlations with computerized tomography presentation","volume":"14","author":"Elad","year":"2010","journal-title":"Clin Oral Investig."},{"key":"2024020318380409200_jbmr1894-bib-0058","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.3174\/ajnr.A0518","article-title":"Imaging findings of bisphosphonate-associated osteonecrosis of the jaws","volume":"28","author":"Phal","year":"2007","journal-title":"AJNR Am J Neuroradiol."},{"key":"2024020318380409200_jbmr1894-bib-0059","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.oooo.2012.08.457","article-title":"Histopathological features of bisphosphonate-associated osteonecrosis: findings in patients treated with partial mandibulectomies","volume":"114","author":"Cho","year":"2012","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol."},{"key":"2024020318380409200_jbmr1894-bib-0060","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.amjmed.2010.04.033","article-title":"Nonexposed variant of bisphosphonate-associated osteonecrosis of the jaw: a case series","volume":"123","author":"Fedele","year":"2010","journal-title":"Am J Med."},{"key":"2024020318380409200_jbmr1894-bib-0061","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1016\/j.joms.2010.05.003","article-title":"Radiographic findings in bisphosphonate-treated patients with stage 0 disease in the absence of bone exposure","volume":"68","author":"Hutchinson","year":"2010","journal-title":"J Oral Maxillofac Surg."},{"key":"2024020318380409200_jbmr1894-bib-0062","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/j.joms.2008.02.012","article-title":"Nonexposed bisphosphonate-related osteonecrosis of the jaws: another clinical variant?","volume":"66","author":"Junquera","year":"2008","journal-title":"J Oral Maxillofac Surg."},{"key":"2024020318380409200_jbmr1894-bib-0063","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1601-0825.2012.01911.x","article-title":"Non-exposed bisphosphonate-related osteonecrosis of the jaw: a critical assessment of current definition, staging, and treatment guidelines","volume":"18","author":"Patel","year":"2012","journal-title":"Oral Dis."},{"key":"2024020318380409200_jbmr1894-bib-0064","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1359\/jbmr.0707onj","article-title":"Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research","volume":"22","author":"Khosla","year":"2007","journal-title":"J Bone Miner Res."}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjbmr.1894","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/28\/7\/1631\/56563828\/jbmr1894.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/28\/7\/1631\/56563828\/jbmr1894.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T10:48:54Z","timestamp":1710326934000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/28\/7\/1631-1640\/7598718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,20]]},"references-count":64,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2013,2,20]]},"published-print":{"date-parts":[[2013,7,1]]}},"URL":"https:\/\/doi.org\/10.1002\/jbmr.1894","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2013,7,1]]},"published":{"date-parts":[[2013,2,20]]}}}